Hi all MSB shareholders,
Feels like the calm before the storm.
Storm = FDA approval of Rem-L for paediatric aGVHD
I am feeling confident because,
- MSB sole focus has been on delivering Manufacturing Quality Control Measures (@ world class Lonza facility in Singapore) that describe manufacturing assays confirming in-vitro and in-vivo cell potency for Rem-L for aGVHD.
- The above has occurred with FDA consultation because, the FDA have approved and Accepted Mesoblast's BLA Resubmission for Remestemcel-L for aGVHD else they would have not approved the resubmission or booked the Lonza inspection in Singapore.
- Once Rem-L is approved on Aug 2, 2023 (not long now) or before, this means in essence, that those manufacturing assays can be applied/accepted for all other MSB cell block buster products including aGVHD for adults, CLBP, CHF, Crohn's, All cause ARDS, Diabetes etc. and all other inflammatory disease treatments in our pipeline.
- The significance of FDA approval, is essentially that FDA are approving MSB allogenic stem cells as a product!!, so only the results of our magnificent trials for blockbuster CHF, CLBP, Crohn's, ARDS and many more to follow, matters when it comes to FDA approval
IMO, now just a waiting game as the the build up of FOMO kicks in and significant wealth increase for MSB shareholders over the short and long term.
IMO
GLTAH
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Hi all MSB shareholders,Feels like the calm before the...
-
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 94863 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 5000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 85863 | 1.125 |
3 | 60500 | 1.120 |
3 | 49858 | 1.115 |
10 | 234700 | 1.110 |
3 | 20500 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 1000 | 1 |
1.135 | 15000 | 2 |
1.140 | 10000 | 1 |
1.150 | 27892 | 3 |
1.155 | 25000 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |